Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
NCT00220116
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
172
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
Capecitabine, Oxaliplatin
Sponsor
Royal Marsden NHS Foundation Trust